ChemoGLO and BD collaborate to advance hazardous drug (HD) testing in healthcare settings to improve staff safety. This collaboration enables facilities to combine the point-of-care qualitative results from the BD HD Check System—available in 10 minutes—with ChemoGLO’s liquid chromatography-mass spectrometry (LC-MS) analysis, helping to deliver a comprehensive quantitative report on an expanded panel of hazardous drugs. Once a sample is collected with the HD Check collection kit, it can be packaged and shipped to ChemoGLO, which provides quantitative results within 3 to 5 days of sample receipt.